Harvard Bioscience to develop its regenerative medicine products

Harvard Bioscience to develop its regenerative medicine products
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.

Read more on News-Medical-Net

---

Orignal From: Harvard Bioscience to develop its regenerative medicine products